Bristol-Myers Squibb (NYSE:BMY) recently received European Commission approval for its Opdivo regimen in treating resectable ...

Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Shares of Bristol Myers Squibb Co. rose 3.83% to $45.81 Thursday, on what proved to be an all-around great trading session ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Robert F. Kennedy Jr. cited Bernie Sanders' 2016 and 2020 White House campaign plans on prescription drugs to highlight Trump ...

The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

The risk calculator shows improved precision in a population larger than the original dataset used to validate the tool.

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...